Cargando…

Experimental Drugs for Panic Disorder: An Updated Systematic Review

Several effective pharmacological therapies for panic disorder (PD) are available, but they have some drawbacks, and unsatisfactory outcomes can occur. Expanding the variety of anti-panic medications may allow for improving PD treatment. The authors performed an updated systematic review of preclini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caldirola, Daniela, Alciati, Alessandra, Cuniberti, Francesco, Perna, Giampaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055642/ https://www.ncbi.nlm.nih.gov/pubmed/33889031 http://dx.doi.org/10.2147/JEP.S261403

Ejemplares similares

Expert opinion in panic disorder: The impact of COVID-19-related fears, protective devices, and lockdown on panic and agoraphobia
por: Caldirola, Daniela, et al.
Publicado: (2021)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020)

Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines
por: Perna, Giampaolo, et al.
Publicado: (2016)

Is panic disorder a disorder of physical fitness? A heuristic proposal
por: Perna, Giampaolo, et al.
Publicado: (2018)

Impact of respiratory protective devices on respiration: Implications for panic vulnerability during the COVID-19 pandemic.
por: Perna, Giampaolo, et al.
Publicado: (2020)

Management of Treatment-Resistant Panic Disorder
por: Perna, Giampaolo, et al.
Publicado: (2017)

Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression
por: Perna, Giampaolo, et al.
Publicado: (2016)

Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress
por: Caldirola, Daniela, et al.
Publicado: (2019)

COVID-19 and panic disorder: clinical considerations for the most physical of mental disorders
por: Perna, Giampaolo, et al.
Publicado: (2020)

Cardiorespiratory Assessments in Panic Disorder Facilitated by Wearable Devices: A Systematic Review and Brief Comparison of the Wearable Zephyr BioPatch with the Quark-b2 Stationary Testing System
por: Caldirola, Daniela, et al.
Publicado: (2023)

First-onset major depression during the COVID-19 pandemic: A predictive machine learning model
por: Caldirola, Daniela, et al.
Publicado: (2022)

Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry
por: Alciati, Alessandra, et al.
Publicado: (2022)

No Sex Differences in Self-Reported Childhood Maltreatment in Major Depressive and Bipolar Disorders: A Retrospective Study
por: Caldirola, Daniela, et al.
Publicado: (2022)

Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
por: Perna, Giampaolo, et al.
Publicado: (2020)

Commentary: Cognitive Behavioral Therapy vs. Eye Movement Desensitization and Reprocessing for Treating Panic Disorder: A Randomized Controlled Trial
por: Perna, Giampaolo, et al.
Publicado: (2018)

Balance Rehabilitation with Peripheral Visual Stimulation in Patients with Panic Disorder and Agoraphobia: An Open-Pilot Intervention Study
por: Caldirola, Daniela, et al.
Publicado: (2023)

Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
por: Daccò, S., et al.
Publicado: (2021)

New onset of mental disorders, lifestyle changes, and quality of relationships during COVID-19 in italian population
por: Caldirola, D., et al.
Publicado: (2021)

C-reactive protein in a naturalistic sample of inpatients with major depressive disorder, bipolar disorder and obsessive-compulsive disorder
por: Caldirola, D., et al.
Publicado: (2021)

Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
por: Perna, Giampaolo, et al.
Publicado: (2011)

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
por: Zugliani, Morena M., et al.
Publicado: (2019)

Genetic Biomarkers of Panic Disorder: A Systematic Review
por: Tretiakov, Artemii, et al.
Publicado: (2020)

Short-Term Psychiatric Rehabilitation in Major Depressive and Bipolar Disorders: Neuropsychological-Psychosocial Outcomes
por: Perna, Giampaolo, et al.
Publicado: (2017)

Assessing vulnerability to panic: a systematic review of psychological and physiological responses to biological challenges as prospective predictors of panic attacks and panic disorder
por: Robinaugh, Donald J, et al.
Publicado: (2019)

Special issue editorial: Personalized medicine in psychiatry in the COVID-19 era: Fighting the impact of the pandemic on mental health
por: Perna, Giampaolo, et al.
Publicado: (2021)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Acid–base dysregulation and chemosensory mechanisms in panic disorder: a translational update
por: Vollmer, L L, et al.
Publicado: (2015)

Pharmacological management of panic disorder
por: Marchesi, Carlo
Publicado: (2008)

The Genetic Basis of Panic Disorder
por: Na, Hae-Ran, et al.
Publicado: (2011)

Tryptophan Research in Panic Disorder
por: Maron, Eduard, et al.
Publicado: (2008)

Experimental panic provocation in healthy man—a translational role in anti-panic drug development?
por: Kellner, Michael
Publicado: (2011)

Panic disorder respiratory subtype: psychopathology and challenge tests – an update
por: Okuro, Renata T., et al.
Publicado: (2020)

Correction: Assessing vulnerability to panic: a systematic review of psychological and physiological responses to biological challenges as prospective predictors of panic attacks and panic disorder
Publicado: (2020)

Panic Disorder: Is the PAG Involved?
por: Del-Ben, Cristina Marta, et al.
Publicado: (2009)

Panic Disorder as Unthinkable Emotions: Alexithymia in Panic Disorder, a Croatian Cross-Sectional Study
por: Šago, Daniela, et al.
Publicado: (2020)

Panic disorders: The role of genetics and epigenetics
por: Kim, Eun Jeong, et al.
Publicado: (2018)

Biological and Clinical Markers in Panic Disorder
por: Cosci, Fiammetta, et al.
Publicado: (2019)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten, Katarzyna, et al.
Publicado: (2016)

Cytokine profile in drug-naïve panic disorder patients
por: Quagliato, Laiana A., et al.
Publicado: (2022)

A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures
por: Grassi, Massimiliano, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_42svegou507ear3krqrogrrt34